AIM IMMUNOTECH INC. (AIM) Operating Margin
- Operating margin · 12 months: Value -11724.21%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -11724.21% | Operating income / revenue. Period ending 2026-06-30. $-11.14M ÷ $95.00K × 100 ≈ -11724.21% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -11.14M USD | Operating Income (Loss) |
| Revenue | 95.00K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 2.74M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-11.14M | $95.00K | (m) | $2.74M | (m) | -11724.21% |
| 2026-03-31 | $-10.27M | $94.00K | (m) | $3.33M | (m) | -10926.60% |
| 2025-12-31 | $-11.66M | $88.00K | (m) | $3.92M | (m) | -13254.55% |
| 2025-09-30 | $-14.57M | $112.00K | (m) | $4.53M | (m) | -13006.25% |
| 2025-06-30 | $-16.61M | $121.00K | (m) | $5.36M | (m) | -13726.45% |
| 2025-03-31 | $-17.66M | $146.00K | (m) | $5.33M | (m) | -12093.84% |
| 2024-12-31 | $-19.77M | $170.00K | (m) | $6.20M | (m) | -11630.59% |
| 2024-09-30 | $-27.92M | $190.00K | (m) | $7.73M | (m) | -14695.26% |
| 2024-06-30 | $-31.59M | $201.00K | (m) | $9.03M | (m) | -15715.92% |
| 2024-03-31 | $-33.35M | $193.00K | (m) | $10.84M | (m) | -17282.38% |
| 2023-12-31 | $-31.92M | $202.00K | (m) | $10.94M | (m) | -15800.00% |
| 2023-09-30 | $-23.47M | $193.00K | (m) | $9.85M | (m) | -12159.59% |
| 2023-06-30 | $-21.83M | $168.00K | (m) | $8.48M | (m) | -12994.64% |
| 2023-03-31 | $-21.07M | $157.00K | (m) | $8.01M | (m) | -13417.83% |
| 2022-12-31 | $-19.92M | $141.00K | (m) | $6.99M | (m) | -14129.79% |
| 2022-09-30 | $-21.81M | $135.00K | (m) | $7.81M | (m) | -16157.04% |
| 2022-06-30 | $-19.22M | $147.00K | (m) | $8.44M | (m) | -13076.19% |
| 2022-03-31 | $-18.25M | $140.00K | (m) | $7.28M | (m) | -13032.14% |
| 2021-12-31 | $-18.84M | $135.00K | (m) | $7.67M | (m) | -13954.07% |
| 2021-09-30 | $-16.54M | $127.00K | (m) | $7.02M | (m) | -13025.98% |
| 2021-06-30 | $-15.97M | $130.00K | (m) | $6.12M | (m) | -12282.31% |
| 2021-03-31 | $-15.57M | $146.00K | (m) | $6.25M | (m) | -10665.75% |
| 2020-12-31 | $-15.15M | $163.00K | (m) | $5.72M | (m) | -9295.71% |
| 2020-09-30 | $-13.09M | $171.00K | (m) | $4.88M | (m) | -7654.97% |
| 2020-06-30 | $-12.94M | $196.00K | (m) | $4.97M | (m) | -6602.55% |
| 2020-03-31 | $-12.84M | $185.00K | (m) | $4.62M | (m) | -6941.62% |
| 2019-12-31 | $-12.44M | $140.00K | (m) | $4.65M | (m) | -8887.86% |
| 2019-09-30 | $-12.02M | $330.00K | (m) | $4.20M | (m) | -3641.21% |
| 2019-06-30 | $-11.85M | $307.00K | (m) | $4.61M | (m) | -3859.61% |
| 2019-03-31 | $-11.85M | (m) | (m) | $4.85M | (m) | (m) |
| 2018-12-31 | $-11.50M | $367.00K | (m) | $4.78M | (m) | -3132.43% |
| 2018-09-30 | $-11.63M | $177.00K | (m) | $4.61M | (m) | -6569.49% |
| 2018-06-30 | $-11.24M | $229.00K | (m) | $3.80M | (m) | -4909.17% |
| 2018-03-31 | $-10.74M | $409.00K | (m) | $3.56M | (m) | -2627.14% |
| 2017-12-31 | $-11.42M | $437.00K | (m) | $4.10M | (m) | -2612.36% |
| 2017-09-30 | $-12.71M | $403.00K | (m) | $5.15M | (m) | -3153.35% |
| 2017-06-30 | $-13.28M | $335.00K | (m) | $5.70M | (m) | -3964.78% |
| 2017-03-31 | $-13.37M | $137.00K | (m) | $5.50M | (m) | -9756.20% |
| 2016-12-31 | $-13.80M | $92.00K | (m) | $5.11M | (m) | -15004.35% |
| 2016-09-30 | $-12.56M | $103.00K | (m) | $4.20M | (m) | -12196.12% |
| 2016-06-30 | $-13.32M | $104.00K | (m) | $4.83M | (m) | -12806.73% |
| 2016-03-31 | $-15.41M | $136.00K | (m) | $6.37M | (m) | -11327.94% |
| 2015-12-31 | $-16.65M | $133.00K | (m) | $8.04M | (m) | -12518.80% |
| 2015-09-30 | $-18.38M | $146.00K | (m) | $9.52M | (m) | -12589.04% |
| 2015-06-30 | $-18.73M | $168.00K | (m) | $9.45M | (m) | -11146.43% |
| 2015-03-31 | $-18.91M | $157.00K | (m) | $9.34M | (m) | -12044.59% |
| 2014-12-31 | $-19.10M | $197.00K | (m) | $8.99M | (m) | -9694.92% |
| 2014-09-30 | $-17.94M | $193.00K | (m) | $8.08M | (m) | -9294.30% |
| 2014-06-30 | $-18.07M | $184.00K | (m) | $8.36M | (m) | -9819.57% |
| 2014-03-31 | $-17.72M | $184.00K | (m) | $8.35M | (m) | -9628.80% |
| 2013-12-31 | $-17.17M | $150.00K | (m) | $8.36M | (m) | -11444.67% |
| 2013-09-30 | $-21.75M | $167.00K | (m) | $10.58M | (m) | -13023.95% |
| 2013-06-30 | $-22.26M | $170.00K | (m) | $10.76M | (m) | -13091.76% |
| 2013-03-31 | $-21.16M | $183.00K | (m) | $10.18M | (m) | -11560.11% |
| 2012-12-31 | $-20.34M | $213.00K | (m) | $9.51M | (m) | -9549.30% |
| 2012-09-30 | $-16.25M | $198.00K | (m) | $7.47M | (m) | -8204.55% |
| 2012-06-30 | $-14.84M | $204.00K | (m) | $6.86M | (m) | -7273.04% |
| 2012-03-31 | $-14.45M | $191.00K | (m) | $6.75M | (m) | -7566.49% |
| 2011-12-31 | $-14.29M | $161.00K | (m) | $6.72M | (m) | -8878.88% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-16.39M | $135.00K | (m) | $7.61M | (m) | -12138.52% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-13.26M | $111.00K | (m) | $7.00M | (m) | -11949.55% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |